ANTARES PHARMA INC's ticker is ATRS and the CUSIP is 036642106. A total of 161 filers reported holding ANTARES PHARMA INC in Q4 2019. The put-call ratio across all filers is 5.95 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2022 | $328,000 | +14.7% | 80,000 | 0.0% | 0.05% | +20.5% |
Q4 2021 | $286,000 | -1.7% | 80,000 | 0.0% | 0.04% | -8.3% |
Q3 2021 | $291,000 | -16.6% | 80,000 | 0.0% | 0.05% | -12.7% |
Q2 2021 | $349,000 | +6.1% | 80,000 | 0.0% | 0.06% | +1.9% |
Q1 2021 | $329,000 | -17.5% | 80,000 | -20.0% | 0.05% | -27.0% |
Q4 2020 | $399,000 | +47.8% | 100,000 | 0.0% | 0.07% | +23.3% |
Q3 2020 | $270,000 | -1.8% | 100,000 | 0.0% | 0.06% | -7.7% |
Q2 2020 | $275,000 | +16.5% | 100,000 | 0.0% | 0.06% | -5.8% |
Q1 2020 | $236,000 | -29.3% | 100,000 | 0.0% | 0.07% | -12.7% |
Q3 2019 | $334,000 | +1.5% | 100,000 | 0.0% | 0.08% | +8.2% |
Q2 2019 | $329,000 | +8.6% | 100,000 | 0.0% | 0.07% | +1.4% |
Q1 2019 | $303,000 | +11.4% | 100,000 | 0.0% | 0.07% | -5.3% |
Q4 2018 | $272,000 | -19.0% | 100,000 | 0.0% | 0.08% | +4.1% |
Q3 2018 | $336,000 | +30.2% | 100,000 | 0.0% | 0.07% | +21.7% |
Q2 2018 | $258,000 | -68.9% | 100,000 | -73.4% | 0.06% | -86.5% |
Q2 2011 | $830,000 | +22.8% | 375,500 | 0.0% | 0.44% | +25.1% |
Q1 2011 | $676,000 | – | 375,500 | – | 0.35% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Sargent Investment Group, LLC | 3,096,355 | $8,422,000 | 5.18% |
JW Asset Management, LLC | 1,920,524 | $5,224,000 | 3.85% |
Healthcare Value Capital, LLC | 250,000 | $680,000 | 2.64% |
ARMISTICE CAPITAL, LLC | 10,300,000 | $28,016,000 | 2.12% |
Broadfin Capital, LLC | 3,444,147 | $9,368,000 | 1.23% |
PERKINS CAPITAL MANAGEMENT INC | 409,000 | $1,112,000 | 0.86% |
MYCIO WEALTH PARTNERS, LLC | 1,896,500 | $5,158,000 | 0.48% |
ESSEX INVESTMENT MANAGEMENT CO LLC | 1,012,600 | $2,754,000 | 0.22% |
FALCON POINT CAPITAL, LLC | 130,200 | $354,000 | 0.21% |
Brown Advisory Securities, LLC | 275,000 | $781,000 | 0.15% |